ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 643859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 643859; 2) Community: the network communities that were significantly associated with the response to NSC 643859; 3) Molecule: the relationships between components within communities and NSC 643859; 4) MDR: the compounds that were significantly associated with the NSC 643859.

NSC Compound Enrichment Correlation
NSC 681231 Boronic acid, [1-[[3-(1-naphthalenyl)-2-[(4-morpholinyl carbonyl)amino]-1-oxopropyl]amino]-3-methylbutyl]-, D-(S)- 0.0339770934764516 0.51755241
NSC 681644 Camptothecin Derivative 0.0339770934764516 0.25394451
NSC 683557 Camptothecin Derivative 0.0339770934764516 0.27746616
NSC 701109 Null 0.0339770934764516 -0.17212549
NSC 705973 10,26-Dioxabicyclo[23.3.1]nonacosa- 5,7,13,19,28-pentaene-11-undecanoic acid, 29-hydroxy-.gamma.,.iota.,3,15,17,21,23-heptamethoxy- .delta.,.theta.,.kappa.,5,12,18,24-heptamethyl- .epsilon.,9,27-trio 0.0339770934764516 0.10865515
NSC 718191 Null 0.0339770934764516 0.3622225
NSC 725202 Null 0.0339770934764516 0.37358176
NSC 732661 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]i soquinoline 0.0339770934764516 -0.081513703
NSC 734758 Null 0.0339770934764516 0.29993055
NSC 735407 Null 0.0339770934764516 0.29530649
Total:84  Current:58    [First] [Prev] [Next] [Last]